Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Grunenthal GmbH
BioCentury | Jan 11, 2025
Management Tracks
Faces in new places ahead of JPM: Rubin joining Guggenheim
Week’s management moves include new venture partners at Frazier and updates from Beigene, Intellia and more
BioCentury | Jan 10, 2025
Management Tracks
Odyssey hires Jason Haas as CFO
Plus: CMO changes at Centessa, Lifordi, Rapport and Gemma, and updates from Peptone, Labgenius, Mitorx and more
BioCentury | Oct 1, 2024
Management Tracks
Prothena names Swanson CDO
Plus: Chris Williams at the helm of Culture, GentiBio scoops up former Structure CMO and updates on Burning Rock, National Resilience and Grünenthal
BioCentury | Nov 22, 2022
Management Tracks
New CEOs named at Oxford, Angelini
Plus: Hegde becomes CSO at Congruence, and updates from Medivir and Grunenthal
BioCentury | Jul 15, 2022
Politics, Policy & Law
July 14 Quick Takes: Illumina, BGI end U.S. legal battle
Plus FDA delays BeiGene’s BLA, Manifold raises $40M and updates from Theravance, Marinus, and more
BioCentury | Jul 24, 2020
Product Development
July 23 Quick Takes: Priority Review for Aurinia; plus Jazz, CymaBay, Biogen, Vertex, Grünenthal, Mesoblast, BMS and Genfit
BioCentury | Apr 20, 2018
Company News
Grunenthal, KU Leuven partner to develop non-opioid pain candidates
Items per page:
1 - 10 of 31